Qiagen Secures FDA Clearance for QIAstat-Dx Gastrointestinal Panel

Ovation.io Launches Groundbreaking GLP-1 Research Dataset to Advance Precision Medicine

Kotak Invests ₹940 Crore in Neuberg Diagnostics to Drive Expansion and IPO Preparation

NICE Recommends Olaparib for BRCA-Mutated Advanced Breast Cancer

SOPHiA GENETICS and Platomics Collaborate to Streamline IVDR Compliance for Clinical Labs

India Unveils Genome Sequencing Data of 10,000 Individuals: A Milestone in Biotechnology Research

Ambry Genetics Advances BRCA2 Variant Classification with CRISPR-Based Study Published in *Nature*

Geneoscopy Secures $105M Series C Funding to Advance Colorectal Cancer Screening

Vertex and Orna Partner to Develop In Vivo Gene Therapies for Blood Disorders

FDA Grants Priority Review to Dizal’s Sunvozertinib for EGFR Exon20ins NSCLC

MD Anderson and Myriad Genetics Forge Strategic Alliance to Advance MRD Testing in Cancer Care

Pillar Biosciences Partners with MSK to Enhance Precision Oncology with OncoKB™ Integration

CytoMed and SunAct Partner to Advance Allogeneic Gamma Delta T Cell Therapy in India

China’s NMPA Approves Astellas’ Zolbetuximab for Advanced Gastric and GEJ Cancer

Renovaro to Acquire Predictive Oncology in All-Stock Deal

Home
/
update
/
details

Thermo Fisher Partners with Telangana Government to Launch Bioprocess Design Centre in Hyderabad

NextEdge Admin

24 Oct 2024

1 min 28 sec

Fortune 500 company Thermo Fisher Scientific, headquartered in Boston, USA, has signed an MoU with the Telangana Government to establish a Bioprocess Design Centre (BDC) in Genome Valley, Hyderabad, announced IT and Industries Minister D. Sridhar Babu. Spanning 10,000 sq. ft., the BDC is expected to become fully operational by the first quarter of 2025.

The MoU was signed at the Minister’s office in the State Secretariat on Wednesday. Sridhar Babu highlighted that the centre will enhance local pharma and life sciences sectors, supporting innovation with advanced labs and research facilities. Telangana, contributing 33% of India’s pharma exports, is also establishing a Skill University to address industry workforce needs.

Additionally, Dr. Reddy’s Laboratories is currently training 80 individuals to bridge skill gaps. The Minister noted that Genome Valley's third phase of expansion is progressing rapidly, and a conference on AI in pharmacy is scheduled for November 18.